ARUP's Cutting-Edge Institute for Advancements in Diagnostic and Precision Medicine: Pioneering the Landscape of Laboratory Medicine

Saturday, September 30, 2023

ARUP Laboratories has introduced the ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine™ (R&I Institute), aimed at advancing patient care through cutting-edge diagnostic and prognostic technologies and innovative testing methods. The primary focus of the R&I Institute is to maximize its positive impact on patients' well-being.

During her tenure as the executive director of PharmaDx, George leveraged her expertise in research, pathology, and clinical trials to develop groundbreaking companion diagnostic tests, including AAV5 DetectCDx™, through collaborations with industry partners. In her current role as CSO and president of the Innovation Business Unit, George has shifted her attention to the R&I Institute.

Notably, the R&I Institute was responsible for the development of the first FDA-approved companion diagnostic immunoassay. The establishment of this dedicated innovation hub marks a significant step forward for ARUP as it redoubles its commitment to fostering creativity and discovery. Innovation plays a pivotal role in the creation of reliable tests, which are crucial for both medical practitioners and patients, ultimately contributing to the delivery of high-quality healthcare. The ultimate goal is to enhance outcomes for the millions of patients who receive care from ARUP each year.



The GIANT Health Event 2023National Healthcare CMO Summit USANational Healthcare CNO Summit USA